Histomorphometry and expression of CDC-47 and caspase-3 in mammary glands of pregnant female rats with artificial hyperthyroidism.
The purpose of this study was to evaluate the effect of hyperthyroidism on mammary gland development and expression of two protein markers, CDC-47 for proliferation and caspase-3 for apoptosis in pregnant female rats. Thirty-six adult female Wistar rats were used in two groups: hyperthyroid and control. Rats were mated 60 days after the onset of thyroxine administration. Six animals/group were sacrificed on gestation days 7, 14, and 19. Artificial hyperthyroidism was induced by daily administration of thyroxine in the drinking water until the end of gestation. At the end of each period, rats were sacrificed, and their inguinal mammary glands were collected and processed for morphometric analysis. The percentages of epithelium, stroma, adipose tissue, and lacteal secretion were determined. Immunohistochemical analysis was also carried out using anti-CDC-47 and anti-caspase-3 antibodies to study proliferation and apoptosis, respectively. On the 19th day of gestation, thyroxine treatment significantly increased the percentage of mammary epithelium. Hyperthyroidism, however, did not change CDC-47 expression. The hyperthyroid group presented early lactogenesis and significantly larger lacteal secretion on the 19th day of gestation. There was no significant difference in caspase-3 expression between groups in any period. We may conclude that hyperthyroidism accelerates mammary gland development and increases lacteal secretion during gestation without increasing the proliferation rate and the expression of caspase-3.
Leite
Eveline Dias
ED
Departamento de Clínica e Cirurgia Veterinárias, Escola de Veterinária, UFMG, Brazil.
de Freitas
Edmilson Santos
ES
de Almeida Souza
Cintia
C
de Melo Ocarino
Natalia
N
Cassali
Geovanni Dantas
GD
Serakides
Rogéria
R
D000251:Adenosine Triphosphatases / Q000096:biosynthesis*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D053148:Caspase 3 / Q000096:biosynthesis*; D049109:Cell Proliferation / Q000187:drug effects; D004268:DNA-Binding Proteins / Q000096:biosynthesis*; D004195:Disease Models, Animal; D005260:Female; D006980:Hyperthyroidism / Q000139:chemically induced / Q000150:complications*; D007150:Immunohistochemistry; D008321:Mammary Glands, Animal / Q000187:drug effects / Q000196:embryology* / Q000473:pathology*; D064168:Minichromosome Maintenance Complex Component 7; D011247:Pregnancy; D011248:Pregnancy Complications / Q000503:physiopathology*; D051381:Rats; D017208:Rats, Wistar; D013974:Thyroxine / Q000633:toxicity
D004268:DNA-Binding Proteins; D053148:Caspase 3; D000251:Adenosine Triphosphatases; C512202:MCM7 protein, rat; D064168:Minichromosome Maintenance Complex Component 7; D013974:Thyroxine